Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN09166218
ISRCTN09166218
Completed
Not Applicable

Randomised, double blind, placebo-controlled trial for testing the efficacy of a botanical formulation in reducing cold and flu symptoms

Radix Bioresearch Corporation (USA)0 sites60 target enrollmentSeptember 25, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCommon cold and fluInfections and Infestations

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Common cold and flu
Sponsor
Radix Bioresearch Corporation (USA)
Enrollment
60
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 25, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Radix Bioresearch Corporation (USA)

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 60 to 80 years old
  • •2\. Having a normal clinical chemistry profile (tested at baseline)
  • •3\. Physician clearance
  • •4\. Willingness to be randomised to the treatment or placebo groups and adhere to all aspects of the study protocol

Exclusion Criteria

  • •1\. Acute or serious chronic diseases
  • •2\. Currently taking prescription medication or non\-steroidal anti\-inflammatory drugs
  • •3\. Use of vitamin or mineral supplements within the past three months
  • •4\. A history of alcohol or drug abuse
  • •5\. Marked sleep disturbances, serious allergies or salient emotional or mood problems
  • •6\. A history of systemic infection, bone fracture or surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Randomised, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischaemia
ISRCTN58194927eiden University Medical Centre (LUMC) (The Netherlands)40
Completed
Not Applicable
Randomized, double blind, placebo-controlled trial of ubiquinol in a statin-induced mitochondrial dysfunction model in healthy volunteers.
NL-OMON41941Centre for Human Drug Research28
Active, not recruiting
Phase 1
Creon in patients with pancreatic insuffiencyPancreatic InsufficiencyTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2011-006019-73-GBSheffield Teaching Hospitals NHS Foundation Trust2
Completed
Phase 3
A clinical trial to study whether zinc decreases the frequency of disease relapses in patients with frequently relapsing nephrotic syndromeHealth Condition 1: null- Frequently relapsing nephrotic syndrome
CTRI/2008/091/000057I114
Active, not recruiting
Not Applicable
A clinical trial to compare the effectiveness and safety of treating the initial episode of nephrotic syndrome in children for a duration of three months versus six monthsHealth Condition 1: null- Initial episode of steroid sensitive nephrotic syndrome
CTRI/2010/091/001095Indian Council of Medical Research168